pharmaceutical
Taxpayers and Patients Win Second Round on 340B Drug Discount Rule
New final 340B drug discount rule from CMS could save Medicare beneficiaries an estimated $320 million in copayments in 2018 alone
July 18, 2018
The Fourth Circuit Was Right to Reject Price Controls for Generic Drugs
This prudent decision will send a strong message to other state legislatures across the country not to pursue similar legislation.
April 23, 2018
